index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique

Dernières publications

Chiffres clés

53 Publications avec texte intégral

Open Access

75 %

Mots clés

Multi exon skipping Cell homeostasis Gene Expression Regulation/drug effects Duchenne muscular dystrophy Muscle cell fusion Gene modifiers Diseases Dilated Cardiomyopathy Long QT Multiresolution modeling LKB1 Morphogenesis Cells Hear Centronuclear myopathy Muscle hypertrophy Delivery Multi resolution modeling DMO Mdx mouse Animal/physiopathology CaV subunits Animals Becker Muscular Dystrophy Muscle development BMD CTNNB1 LncARN Modificateurs de gènes Dystrophy Antisense oligonucleotides Molecular docking Becker muscular dystrophy BMD Long noncoding RNA Hepatocellular carcinoma Homeostasis Duchenne DMD dystrophy Dystrophie Musculaire de Becker BMD Becker BMD muscular dystrophy Cardiomyopathy Exon skipping Dystrophie musculaire de Becker Autophagy Activin Receptors Humans Génomique MiARN Invivo Mitochondrial fission Cardiomyopathie Knockout Dystrophie Musculaire de Duchenne DMD Muscle damage Human Umbilical Vein Endothelial Cells Gene expression Immunoglobulin Fc Fragments/pharmacology L-Type DHPR α1S Inbred C57BL Metabolism Epigenetics Muscle Dystrophin Mice Inbred mdx Genomic Molecular Sequence Data CaVβs Cultured Adult muscle stem cells Cachexia Heart Failure Clinical trials Becker muscular dystrophy Drp1 Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Dystrophin-EGFP Dystrophine CD38 Allele‐specific silencing therapy Skeletal muscle Base Sequence Duchenne muscular dystrophy DMD Energy Metabolism/drug effects Male Muscle Biology Cell Biology Liver Dystrophin central domain Muscle Strength Calcium Channels Ex-vivo Cell Line MES Connexins Calcium Inhibitors Dynamin 2 DMD LncRNA